LMR Partners LLP
Institutional investor · Portfolio as of Q1 2020
Top Holdings238 positions
| 87.5M | $130.8M | 6.1% | — | — | 1 qtr | New 93 | |
| 65M | $114.3M | 5.3% | — | — | 2 qtrssince 2019-Q4 | Increased 94 | |
| 65M | $107.6M | 5.0% | — | — | 2 qtrssince 2019-Q4 | Increased 94 | |
| 521,900 | $93.9M | 4.4% | — | — | 3 qtrssince 2019-Q3 | Increased 88 | |
| 72.8M | $75.4M | 3.5% | — | — | 2 qtrssince 2019-Q4 | Increased 74 | |
| 40M | $57.8M | 2.7% | — | — | 1 qtr | New 76 | |
INFOSYS LTD | 6.8M | $56.6M | 2.6% | $8.80 | -21.61% | 4 qtrssince 2019-Q2 | Decreased 0 |
TAKEDA PHARMACEUTICAL CO LTD | 3.4M | $53.4M | 2.5% | $15.98 | -8.43% | 5 qtrssince 2019-Q1 | Increased 81 |
| 1M | $44.1M | 2.1% | — | — | 1 qtr | New 75 | |
ICICI BK LTD ADR | 5.3M | $43.9M | 2.0% | $11.11 | -26.04% | 5 qtrssince 2019-Q1 | Decreased 0 |
| 440,839 | $43.4M | 2.0% | — | — | 5 qtrssince 2019-Q1 | Increased 81 | |
COSTAR GROUP INC | 72,000 | $43.2M | 2.0% | $59.83 | -1.85% | 2 qtrssince 2019-Q4 | Unchanged 0 |
| 25M | $42.6M | 2.0% | — | — | 1 qtr | New 67 | |
SONY CORP | 705,367 | $42.1M | 2.0% | $11.67 | 0.00% | 1 qtr | New 67 |
| 18M | $41.7M | 1.9% | — | — | 1 qtr | New 67 | |
SUMITOMO MITSUI FIN GRP INC SPONSORED ADR | 8M | $40.8M | 1.9% | $6.22 | -22.22% | 4 qtrssince 2019-Q2 | Increased 56 |
| 4.6M | $38.8M | 1.8% | — | — | 1 qtr | New 66 | |
MELLANOX TECHNOLOGIES LTD | 320,385 | $38.8M | 1.8% | — | — | 1 qtr | New 66 |
| 30M | $34.2M | 1.6% | — | — | 1 qtr | New 66 | |
TIFFANY & CO NEW | 259,887 | $33.4M | 1.6% | — | — | 1 qtr | New 66 |
LMR Partners LLP manages $2.1B across 238 positions as of Q1 2020. Top holdings: TESLA INC (6.1%), TESLA INC (5.3%), TESLA INC (5.0%). Fund DNA: Diversified Scout. HoldingsIntel Score: 1.5/5.0.
Active quarter - 105 new positions, 258 exits, 38 increased. Top move: HNIB (INCREASED, conviction 88). Portfolio: $2.1B across 238 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR